KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 129 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $762 | +173.1% | 568,298 | +591.7% | 0.06% | +85.7% |
| Q4 2022 | $279 | -100.0% | 82,162 | -57.2% | 0.04% | -77.4% |
| Q4 2021 | $1,234,000 | +19.8% | 191,976 | +8.5% | 0.16% | +47.6% |
| Q3 2021 | $1,030,000 | +242.2% | 176,996 | +507.4% | 0.10% | +208.8% |
| Q2 2021 | $301,000 | -6.5% | 29,138 | -4.8% | 0.03% | -35.8% |
| Q1 2021 | $322,000 | -5.0% | 30,592 | +39.7% | 0.05% | -3.6% |
| Q4 2020 | $339,000 | – | 21,903 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,767,078 | $80,993,000 | 5.22% |
| Palo Alto Investors LP | 4,663,324 | $79,230,000 | 3.17% |
| DOHENY ASSET MANAGEMENT /CA | 282,945 | $4,807,000 | 2.61% |
| Private Capital Advisors, Inc. | 416,900 | $7,083,000 | 2.22% |
| Sandia Holdings, LLC | 119,739 | $2,034,000 | 0.91% |
| Virtus ETF Advisers LLC | 44,986 | $764,000 | 0.68% |
| Birchview Capital, LP | 50,000 | $850,000 | 0.58% |
| Schonfeld Strategic Advisors LLC | 415,600 | $7,061,000 | 0.38% |
| EMERALD ADVISERS, LLC | 561,317 | $9,537,000 | 0.36% |
| Kazazian Asset Management, LLC | 20,672 | $351,000 | 0.32% |